Travere Therapeutics, Inc. · NASDAQ:TVTX
BlackRock, Inc. reported a 7.50% stake in Travere Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 17, 2025
BlackRock, Inc. reported a 7.50% stake in Travere Therapeutics, Inc., 6,689,435 shares, as a passive investor on Mar 31, 2025. Filed Apr 17, 2025 (Schedule 13G/A).
- Stake
- 7.50%
- Shares
- 6,689,435
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.50% | 6,689,435 |
Source
Related
- Travere Therapeutics, Inc.
- BlackRock, Inc.
- Travere Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026